Conference Coverage
Conference Coverage
08/23/2024
Researchers set out to determine whether attention-deficit/hyperactivity disorder predisposes individuals to the development of neuropsychiatric symptoms. The researchers presented their findings at the...
08/23/2024
Research summary
Research summary
07/23/2024
A team of researchers sought to determine the prevalence of depression and anxiety in patients with NMOSD before their diagnosis of the disease.
07/23/2024
covid-19 roundup
covid-19 roundup
06/26/2024
In this COVID-19 roundup, researchers report on an increase in outpatient care following COVID-19 infection, cognition and memory impairment among those recovering from COVID-19, and more.
06/26/2024
Research summary
Research summary
05/23/2024

Jessica Ganga

Jessica Ganga
A team of researchers examined the possibility of harmful risks associated with the discontinuation of long-term benzodiazepine use in patients.
05/23/2024
Research Summary
Research Summary
03/28/2024

Jessica Ganga

Jessica Ganga
Researchers investigated whether survivors of stroke could take two common types of antidepressant medications—SSRIs and SNRIs—and evaluated if serious bleeding occurred among patients. Their findings were...
03/28/2024
research summary
research summary
03/11/2024

Leigh Precopio

Leigh Precopio
Researchers examined how the availability of mental health services and patient specific characteristics impacted levels of anxiety and depression in residents of long-term care settings following COVID-19...
03/11/2024
Research Summary
Research Summary
01/18/2024

Jessica Ganga

Jessica Ganga
Researchers evaluated the prevalence of depression disorders in pediatric patients to determine if there is a mental health impact on this age group.
01/18/2024
research summary
research summary
10/30/2023

Leigh Precopio

Leigh Precopio
Researchers examined trends and patterns of emergency department visits and hospitalizations for suicidality among pediatric patients.
10/30/2023
FDA Alert
FDA Alert
10/04/2023

Jessica Ganga

Jessica Ganga
Following two randomized studies, the FDA has approved zuranolone for the treatment of postpartum depression in adults—the first if its kind.
10/04/2023
COVID-19 Roundup
COVID-19 Roundup
09/26/2023

Jessica Ganga

Jessica Ganga
This COVID-19 roundup includes coverage on the FDA-approved oral antiviral treatment for adults with mild-to-moderate COVID-19, how antidepressant medication may lower the incidence of COVID-19, a study...
09/26/2023